secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2022-02-11T23:59:59+00:00
Accession:  0001558370-22-001035
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Gen. H.R. McMaster to retire from NRX Pharmaceuticals Board at next annual meeting
--------------------------------------------------------------------------------

- Gen. McMaster informed the Board on Feb 7, 2022 that he will retire effective the next Annual Meeting.
- His term would have expired in 2024; he will continue as director until the Annual Meeting.
- No disagreement with the Company cited; McMaster will remain as an advisor.
- Board thanked McMaster for service; company developing NRX-101 for suicidal depression and PTSD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/0001558370-22-001035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/nrxp-20220211x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-001035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer